Aquila enters licensing agreement with Beth Israel for immune system-enhancing antibodies July 10, 2000
Hydrophilic somatostatin analogues for treatment or diagnosis of cancer described by Tulane U. July 6, 2000
First mechanism-based MMP inhibitor designed at Wayne State as potential anticancer agent July 5, 2000
KNK-437: a novel inhibitor of the development of thermotolerance and HSP induction in cancer cells July 5, 2000
RSS